Through enhanced diagnostic, disease prevention and tailored treatments, personalized healthcare holds great promise for each of us. Research in this field was long hindered by technical, interoperability, ethical and legal challenges, which prevented access to a wealth of consented biomedical data from patients. SIB has played a key role in coordinating efforts on the national level, and establishing the Swiss infrastructure which is now boosting research in this field, in which over 20 of our groups are active. We are also part of several European public-private partnerships, several of which aiming to facilitate precision medicine in cancer or diabetes. Through outreach activities, we also inform the public about the promise and challenges of precision medicine and the role of bioinformatics to enable it.
Making sense of health data to guide treatment decisions
Precision medicine and the role of bioinformatics
Bioinformatics is fundamental to precision medicine. But why? How do hospitals...
The Swiss Data Science Center and SIB are joining forces to build a secure data processing environment for personalized health research in Switzerland
First Certificate of Advanced Studies (CAS) in personalized molecular oncology
The University Hospital of Basel is launching a CAS in personalized molecular...
SIB accelerates the fight against diabetes with several pan-European projects
Recent advances in the fight against type 2 diabetes (T2D) result from a pan...